Literature DB >> 31198171

Refractory THSD7A membranous nephropathy with severe asthma related to eosinophilia
.

Tomo Suzuki, Shu Ushimaru, Daisuke Uchida, Shiika Watanabe, Daisuke Ichikawa, Junki Koike, Hidehiko Mizuguchi, Hiroo Kawarazaki, Yugo Shibagaki.   

Abstract

We report a case of a 50-year-old Japanese man with a history of pediatric asthma diagnosed with nephrotic syndrome after 4 years of relapsing asthma with severe eosinophilia. Thrombospondin type-1 domain-containing 7A membranous nephropathy (THSD7A-MN) was diagnosed based on histological evaluation. We started a course of steroid semi-pulse therapy, high-dose oral prednisolone, mizoribine, and cyclosporine. Frequent relapse of asthma was observed after gradual tapering of prednisolone dose to 10 mg/day. After improvement of asthma symptoms and eosinophilia, his serum albumin level increased gradually. Considering the clinical course of refractory MN and asthma, we suggest that THSD7A-MN may be associated with severe asthma and eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31198171     DOI: 10.5414/CN109751

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

1.  Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.

Authors:  Sayuri Shirai; Shin'ichi Akiyama; Atsuko Kamijo-Ikemori; Tomo Suzuki; Daisuke Ichikawa; Junki Koike; Kenjiro Kimura; Yugo Shibagaki
Journal:  CEN Case Rep       Date:  2019-11-08

2.  Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.

Authors:  Tomo Suzuki; Wei Han; Shiika Watanabe; Maho Terashita; Mayumi Nakata; Daisuke Ichikawa; Sayuri Shirai; Yugo Shibagaki
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.